Section Arrow
XENE.NASDAQ
- Xenon Pharmaceuticals
Quotes are at least 15-min delayed:2026/09/18 12:02 EDT
Regular Hours
Last
 40.3363
-17.0137 (-29.67%)
Day High 
44.765 
Prev. Close
57.35 
1-M High
64.93 
Volume 
9.82M 
Bid
40.3
Ask
40.39
Day Low
39.8301 
Open
44.02 
1-M Low
56.17 
Market Cap 
5.55B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 58.47 
20-SMA 59.61 
50-SMA 62.92 
52-W High 72.66 
52-W Low 35.97 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.74/-4.78
Enterprise Value
5.56B
Balance Sheet
Book Value Per Share
12.83
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.50M
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TCRTAlaunos Therapeutics Inc.1.055-0.545-34.06%-- 
XENEXenon Pharmaceuticals40.3284-17.0216-29.68%-- 
PDSBPDS Biotechnology Corp0.7933-0.0489-5.81%-- 
RXRXRecursion Pharmaceuticals3.66+0.12+3.39%-- 
IOVAIovance Biotherapeutics9.945-0.075-0.75%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.